White Matter Alterations in Cognitively Normal apoE ɛ2 Carriers: Insight into Alzheimer Resistance?

References

1. 1.↵
   1. Corder EH,
   2. Saunders AM,
   3. Risch NJ,
   4. et al

   . Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180–84

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Seshadri S,
   2. Drachman DA,
   3. Lippa CF

   . Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 1995;52:1074–79

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Thakkinstian A,
   2. Bowe S,
   3. McEvoy M,
   4. et al

   . Association between apolipoprotein E polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 2006;164:813–22

   Abstract/FREE Full Text
4. 4.↵
   1. Le Bihan D,
   2. Mangin J,
   3. Poupon C,
   4. et al

   . Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534–46

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Song SK,
   2. Sun SW,
   3. Ju WK,
   4. et al

   . Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714–22

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Song SK,
   2. Sun SW,
   3. Ramsbottom MJ,
   4. et al

   . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Zhang Y,
   2. Schuff N,
   3. Jahng GH,
   4. et al

   . Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13–19

   Abstract/FREE Full Text
8. 8.↵
   1. Zhou Y,
   2. Dougherty JH,
   3. Hubner KF,
   4. et al

   . Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement 2008;4:265–70

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Fellgiebel A,
   2. Wille P,
   3. Muller MJ,
   4. et al

   . Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 2004;18:101–08

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Salat DH,
    2. Tuch DS,
    3. van der Kowe AJW,
    4. et al

    . White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 2010;31:244–56

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Bozzali M,
    2. Falini A,
    3. Franceschi M,
    4. et al

    . White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002;72:742–46

    Abstract/FREE Full Text
12. 12.↵
    1. Huang J,
    2. Friedland RP,
    3. Auchus AP

    . Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer's disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol 2007;28:1943–48

    Abstract/FREE Full Text
13. 13.↵
    1. Nierenberg J,
    2. Pomara N,
    3. Hoptman MJ,
    4. et al

    . Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. NeuroReport 2005;16:1369–72

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Persson J,
    2. Lind J,
    3. Larsson A,
    4. et al

    . Altered brain white matter integrity in healthy carriers of the apoE epsilon4 allele: a risk for AD? Neurology 2006;66:1029–33

    Abstract/FREE Full Text
15. 15.↵
    1. Smith CD,
    2. Chebrolu H,
    3. Andersen AH,
    4. et al

    . White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol Aging 2010;31:1122–31

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Scheltens P,
    2. Barkhof F,
    3. Leys D,
    4. et al

    . A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7–12

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage 2006;31:1487–505

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Mori S,
    2. Wakana S,
    3. Nagae-Poetscher LM,
    4. et al

    . MRI Atlas of Human White Matter. Amsterdam: Elsevier; 2005
20. 20.↵
    1. Duvernoy H

    . The Human Hippocampus. 2nd ed. Berlin: Springer-Verlag; 1998: 34
21. 21.↵
    1. Valenstein E,
    2. Bowers D,
    3. Verfaellie M,
    4. et al

    . Retrosplenial amnesia. Brain 1987;110:1631–46

    Abstract/FREE Full Text
22. 22.↵
    1. Minoshima S,
    2. Foster NL,
    3. Kuhl DE

    . Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895

    PubMedWeb of Science
23. 23.↵
    1. Reiman EM,
    2. Caselli RJ,
    3. Yun LS,
    4. et al

    . Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 1996;334:752–58

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Di Paola M,
    2. Di Iulio F,
    3. Cherubini A,
    4. et al

    . When, where, and how the corpus callosum changes in MCI and AD. Neurology 2010;74:1136–42

    Abstract/FREE Full Text
25. 25.↵
    1. Xie S,
    2. Xiao JX,
    3. Gong GL,
    4. et al

    . Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 2006;66:1845–49

    Abstract/FREE Full Text
26. 26.↵
    1. Takahashi S,
    2. Yonezawa H,
    3. Takahashi J,
    4. et al

    . Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett 2002;332:45–48

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Rose SE,
    2. Chen F,
    3. Chalk JB,
    4. et al

    . Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000;69:528–30

    Abstract/FREE Full Text
28. 28.↵
    1. Reisberg B,
    2. Franssen EH,
    3. Souren LE,
    4. et al

    . Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias; management and treatment import. Am J Alzheimers Dis Other Demen 2002;17:202–12

    Abstract/FREE Full Text
29. 29.↵
    1. Brun A,
    2. Englund E

    . A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253–62

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Filippini N,
    2. Zarei M,
    3. Beckmann CF,
    4. et al

    . Regional atrophy of transcallosal prefrontal connections in cognitively normal apoE epsilon4 carriers. J Magn Reson Imaging 2009;29:1021–26

    CrossRefPubMed
31. 31.↵
    1. Schmahmann JD,
    2. Pandya DN

    . Fiber Pathways of the Brain. Oxford: Oxford University Press; 2006: 133–35
32. 32.↵
    1. Medina D,
    2. DeToledo-Morell L,
    3. Urresta F,
    4. et al

    . White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging 2006;27:663–72

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Rose SE,
    2. McMahon KL,
    3. Janke AL,
    4. et al

    . Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 2006;77:1122–28

    Abstract/FREE Full Text
34. 34.↵
    1. Wiegell MR,
    2. Tuch DS,
    3. Larsson HBW,
    4. et al

    . Automatic segmentation of thalamic nuclei from diffusion tensor magnetic resonance imaging. Neuroimage 2003;19:391–401

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Sun SW,
    2. Liang HF,
    3. Trinkaus K,
    4. et al

    . Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 2006;55:302–08

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Concha L,
    2. Gross DW,
    3. Wheatley BM,
    4. et al

    . Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. Neuroimage 2006;32:1090–99

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Gold BT,
    2. Powell DK,
    3. Andersen AH,
    4. et al

    . Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. Neuroimage 2010;52:1487–94

    CrossRefPubMed
38. 38.↵
    1. Stenset V,
    2. Bjornerud A,
    3. Fjell AM,
    4. et al

    . Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment. Neurobiol Aging 2011;32:581–89.

    CrossRefPubMed
39. 39.↵
    1. Bartzokis G

    . Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging 2011;32:1341–71.

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Sjobeck M,
    2. Haglund M,
    3. Englund E

    . Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease—a neuropathological study. Int J Geriatr Psychiatry 2005;20:919–26

    CrossRefPubMed
41. 41.↵
    1. Wang DS,
    2. Bennett DA,
    3. Mufson EJ,
    4. et al

    . Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res 2004;48:93–100

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Roher AE,
    2. Weiss N,
    3. Kokjohn TA,
    4. et al

    . Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002;41:11080–90

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Lippa CF,
    2. Smith TW,
    3. Saunders AM,
    4. et al

    . Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype. Neurology 1997;48:515–19

    Abstract/FREE Full Text
44. 44.↵
    1. Chiang GC,
    2. Insel PS,
    3. Tosun D,
    4. et al

    . Hippocampal atrophy rates and CSF biomarkers in elderly apoE2 normal subjects. Neurology 2010;75:1976–81

    Abstract/FREE Full Text
45. 45.↵
    1. Berlau DJ,
    2. Corrada MM,
    3. Head E,
    4. et al

    . apoE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 2009;72:829–34

    Abstract/FREE Full Text
46. 46.↵
    1. Dumanis SB,
    2. Tesoriero JA,
    3. Babus LW,
    4. et al

    . ApoE 4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 2009;29:15317–22

    Abstract/FREE Full Text
47. 47.↵
    1. Wilson RS,
    2. Bienias JL,
    3. Berry-Kravis E,
    4. et al

    . The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 2002;73:672–77

    Abstract/FREE Full Text